NCT03274973View on ClinicalTrials.gov

Study to Assess Long-term Effectiveness of Zomacton® and Treatment Adherence in Patients With Growth Hormone Deficiency or Ullrich-Turner Syndrome

TerminatedOBSERVATIONAL
Enrollment

4

Participants

Timeline

Start Date

May 14, 2018

Primary Completion Date

October 31, 2018

Study Completion Date

October 31, 2018

Conditions
Growth Disorders
Interventions
DRUG

Zomacton

Injection

Trial Locations (1)

24105

Klinik fuer Allgemeine Paediatrie der Christian-Albrechts-Universitaet zu Kiel (there might be other sites in this country), Kiel

Sponsors
All Listed Sponsors
lead

Ferring Pharmaceuticals

INDUSTRY

NCT03274973 - Study to Assess Long-term Effectiveness of Zomacton® and Treatment Adherence in Patients With Growth Hormone Deficiency or Ullrich-Turner Syndrome | Biotech Hunter | Biotech Hunter